Viz.ai

Viz.ai provides an AI-powered disease detection and intelligent care coordination platform for time-sensitive conditions including stroke, pulmonary embolism, and aortic dissection. The company's FDA-cleared AI algorithms analyze medical imaging to identify critical cases and automatically alert specialist care teams, reducing time to treatment. Viz.ai has raised over $250M in funding and serves 1,400+ hospitals across the U.S. and internationally. The platform analyzes millions of CT scans annually, with clinical studies showing 52-minute reduction in treatment times for stroke patients.